Desmopressin Acetate
| 證據等級: L5 | 預測適應症: 0 個 |
目錄
Desmopressin Acetate: Evaluation Halted — No Repurposing Predictions Available
One-Sentence Summary
Desmopressin Acetate is a synthetic analogue of vasopressin (antidiuretic hormone), clinically recognised for treating central diabetes insipidus, nocturnal enuresis, and coagulation disorders such as mild Haemophilia A and von Willebrand disease type 1. This Evidence Pack contains no TxGNN predicted indications, so a formal repurposing evaluation cannot be completed at this stage. A Hold decision is recommended until the minimum required data are collected.
Quick Overview
| Item | Content |
|---|---|
| Original Indication | Not recorded in this Evidence Pack |
| Predicted New Indication | None available |
| TxGNN Prediction Score | N/A |
| Evidence Level | Insufficient data — below L5 |
| Taiwan Market Status | 未上市 (Not marketed) |
| Number of Authorizations | 0 |
| Recommended Decision | Hold |
Safety Considerations
Please refer to the package insert for safety information.
Conclusion and Next Steps
Decision: Hold
Rationale: This Evidence Pack returned zero TxGNN predicted indications, no original indication records, no mechanism of action, and no safety data — the minimum inputs required for a repurposing evaluation are absent.
To proceed, the following is needed:
- TxGNN model output — predicted indications with confidence scores must be generated before any evaluation can begin
- Mechanism of action (MOA) — DrugBank query returned 1 result but the data was not ingested into the Evidence Pack; re-run the extraction pipeline (DG002, severity: High)
- Taiwan package insert warnings and contraindications — TFDA 仿單 PDF must be parsed (DG001, severity: Blocking)
- Drug-drug interaction (DDI) data — current query returned
not_found; cross-reference with international DDI databases (e.g., Lexicomp, Micromedex) - Original indication mapping —
original_indicationsis an empty array; populate from TFDA licence records or DrugBank approved indicationsDisclaimer
This content is for research purposes only and does not constitute medical advice. Clinical validation is required before any clinical application.